They would be off to use that money for a few partnerships with small med company's with something promising in the pipeline. Or increase the sale team. That'll bring a bit of spec back into the stock.
They would be off to use that money for a few partnerships with...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)